This site is intended only for healthcare professionals resident in the Republic of Ireland
Enbrel® is a TNF inhibitor approved for treating multiple chronic diseases in rheumatology and dermatology2
Etanercept is manufactured in Pfizer's state-of the-art manufacturing facility in Grange Castle, Dublin.6
Enbrel® is a soluble tumour necrosis factor (TNF) receptor fusion protein2
Enbrel is approved across 7 therapeutic indications, including paediatric indications²
Learn more about the efficacy and safety of Enbrel across licensed indications
Learn about the recommended dosing for Enbrel and the devices available to your patients to help their at-home management
See what resources are available to support you and your patients
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023